C12Y116/01 - CPC Classification Index

ClassID:

114545 ⎘

C12Y116/01 - CPC Classification

Classification description:

Oxidoreductases oxidizing metal ions (1.16) with NAD+ or NADP+ as acceptor (1.16.1)

Sub-classes:

C12Y116/01001 » Mercury(II) reductase (1.16.1.1) 2
C12Y116/01002 » Diferric-transferrin reductase (1.16.1.2) 0
C12Y116/01003 » Aquacobalamin reductase (1.16.1.3) 0
C12Y116/01004 » Cob(II)alamin reductase (1.16.1.4) 0
C12Y116/01005 » Aquacobalamin reductase (NADPH) (1.16.1.5) 0
C12Y116/01006 » Cyanocobalamin reductase (cyanide-eliminating) (1.16.1.6) 0
C12Y116/01007 » Ferric-chelate reductase (NADH) (1.16.1.7) 1
C12Y116/01008 » [Methionine synthase] reductase (1.16.1.8) 0
C12Y116/01009 » Ferric-chelate reductase (NADPH) (1.16.1.9) 0

Recent Application in this class:

20250101399

2025-03-27

Consensus Prostate Antigens, Nucleic Acid Molecule Encoding The Same And Vaccine And Uses Comprising The Same

20230338489

2023-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

20220354936

2022-11-10

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

20220323559

2022-10-13

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

20220280623

2022-09-08

Peptides and combination of peptides for use in immunotherapy against various cancers

20220280622

2022-09-08

Peptides and combination of peptides for use in immunotherapy against various cancers

20220273783

2022-09-01

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

20220265795

2022-08-25

Peptides and combination of peptides for use in immunotherapy against various cancers

20220265794

2022-08-25

Peptides and combination of peptides for use in immunotherapy against various cancers

#10

20220265793

2022-08-25

Peptides and combination of peptides for use in immunotherapy against various cancers

#11

20220257738

2022-08-18

Peptides and combination of peptides for use in immunotherapy against various cancers

#12

20220257736

2022-08-18

Peptides and combination of peptides for use in immunotherapy against various cancers

#13

20220249635

2022-08-11

Peptides and combination of peptides for use in immunotherapy against various cancers

#14

20220016228

2022-01-20

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

#15

20210353728

2021-11-18

Peptides and combination of peptides for use in immunotherapy against various cancers

#16

20210346481

2021-11-11

Peptides and combination of peptides for use in immunotherapy against various cancers

#17

20210290745

2021-09-23

Peptides and combination of peptides for use in immunotherapy against various cancers

#18

20210290744

2021-09-23

Peptides and combination of peptides for use in immunotherapy against various cancers

#19

20210283231

2021-09-16

Peptides and combination of peptides for use in immunotherapy against various cancers

#20

20210275656

2021-09-09

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

#21

20200093906

2020-03-26

Peptides and combination of peptides for use in immunotherapy against various cancers

#22

20200000902

2020-01-02

Peptides and combination of peptides for use in immunotherapy against various cancers

#23

20190269767

2019-09-05

Peptides and combination of peptides for use in immunotherapy against various cancers

#24

20190262444

2019-08-29

Peptides and combination of peptides for use in immunotherapy against various cancers

#25

20190046621

2019-02-14

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

#26

20190015492

2019-01-17

Peptides and combination of peptides for use in immunotherapy against various cancers

#27

20180360937

2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

#28

20180360936

2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

#29

20170189513

2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#30

20170189512

2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#31

20170189511

2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#32

20170189510

2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#33

20170189509

2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#34

20170189506

2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#35

20170189505

2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#36

20170165338

2017-06-15

Peptides and combination of peptides for use in immunotherapy against various cancers

#37

20160361403

2016-12-15

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

#38

20160274116

2016-09-22

Compositions and methods for prostate cancer analysis

#39

20150150957

2015-06-04

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

#40

20130143237

2013-06-06

COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS